U.S. overdose deaths fell by about 14% in 2025 to approximately 70,000, marking the third consecutive year of decline and returning to pre-pandemic levels, according to preliminary government data released Wednesday.
Key Takeaways
U.S. overdose deaths fell by about 14% in 2025 to approximately 70,000, marking the third consecutive year of decline and returning to pre-pandemic levels. While experts are cautiously optimistic, concerns arise over policy changes and emerging drugs like cychlorphine.
- U.S. overdose deaths dropped by about 14% in 2025
- Total deaths reached approximately 70,000, matching pre-pandemic levels
- Declines seen across various drug types including fentanyl, cocaine, and methamphetamine
- Seven states saw increases, with Arizona, Colorado, and New Mexico experiencing jumps of 10% or more
The declines were seen across various drug types, including fentanyl, cocaine, and methamphetamine. Overdose deaths fell in most states, although seven saw increases, with Arizona, Colorado, and New Mexico experiencing jumps of 10% or more. The Centers for Disease Control and Prevention (CDC) provided the preliminary data.
Experts are cautiously optimistic about the decline but warn that policy changes and shifts in the drug supply could reverse progress. Brandon Marshall, a Brown University researcher who studies overdose trends, noted that while deaths have been decreasing rapidly, they could increase just as quickly if efforts to combat the crisis are relaxed.
The pandemic saw a dramatic spike in overdose deaths, peaking at nearly 110,000 in 2022 due to social isolation and difficulties accessing addiction treatment. As the pandemic waned, deaths declined, with researchers pointing to factors such as increased availability of naloxone, expanded addiction treatment, shifts in drug use patterns, and the impact of opioid lawsuit settlement money.
Health officials have also raised alarms about newer drugs detected in 2025. Alex Krotulski, director of the Center for Forensic Science Research and Education, reported that his lab identified 27 new drugs last year and has already identified 23 new drugs in less than five months into 2026. Among these is cychlorphine, a synthetic opioid up to 10 times stronger than fentanyl, often used as a cutting agent.
The Trump administration has been cutting programs designed to reduce overdose deaths and infections tied to drug use. In a letter last month, the federal Substance Abuse and Mental Health Services Administration notified grant recipients that the government would no longer pay for test strips and kits that help drug users detect highly-lethal additives in their drugs.
How this summary was created
This summary synthesizes reporting from 4 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.